Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1961;9:295-299

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAKO, K.
Right arrow Articles by BING, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAKO, K.
Right arrow Articles by BING, R. J.
(Circulation Research. 1961;9:295.)
© 1961 American Heart Association, Inc.


KYOHEI KAKO M.D.1, ATHANASIOS CHRYSOHOU M.D.1, RICHARD J. BING M.D.1

1 Department of Medicine, Wayne State University College of Medicine, Detroit, Michigan

The factors affecting myocardial storage and release of catecholamines were investi gated. The catecholainine concentration of heart muscle of normal dogs averaged 0.617 g. per Gm. of heart muscle. Ventricular tachycardia, fibrillation, and reserpine caused a slight reduction in myocardial catechol amine concentration, while nicotine resulted in a slight increase. Iproniazid was without effect. The injection of the amino acid, Dopa, and of the combinatiou of Dopa and iproni azid, resulted in a significant elevation of catecholamines in heart muscle.

In animals pretreated with Dopa and iproniazid, nicotine caused a significant in crease in myocardial catecholaniines. It is likely that stimulation of the adrenal medulla and sympathetic nerve endings by nicotine elevated catecholamine levels in blood, with subsequent storage in the heart and other organs.

Submitted on September 13, 1960